Revenue segments as reported by the company.

Premium and service revenues

Premium tax

Revenue Segments

Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Gross Margin

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

Selling, general and administrative

Depreciation

Amortization of acquired intangible assets

Premium tax expense

Health insurer fee expense

Impairment

Legal settlement

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Also known as Price/Sales Ratio. Calculated using Average market cap for the quarter / Annualized quarterly revenue.

Revenue Multiple

Centene

Centene Corp. operates as a healthcare enterprise, which engages in the provision of programs and services to government sponsored healthcare programs. It operates through the following segments: Managed Care and Specialty Services. The Medicaid Managed Care segment provides health plan coverage to individuals through government subsidized programs through Medicaid. The Specialty Services segment offers healthcare services and products to state programs, correctional facilities, healthcare organizations, employer groups, and other commercial organizations. The company was founded in 1984 and is headquartered in St. Louis, MO.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Centene exceeds earnings guidance, eyes growth in Marketplace products

Centene's Q4 2022 earnings call highlighted robust financial performance, successful execution of value-creation plans, and a focus on operational efficiency. While challenges in Medicare Advantage margins are anticipated, opportunities in the Marketplace business and cost-cutting initiatives offer avenues for growth. Strategic initiatives to address demographic shifts and enhance care relationships position Centene for future success.

Centene reports strong Q1 earnings, focuses on growth opportunities

Centene's Q1 performance reflects strength in financial results and a strategic outlook for future growth.
Despite challenges in Medicare profitability and Medicaid redeterminations, Centene remains focused on maximizing membership and maintaining high margins.
Opportunities in enhancing relationships, investing in infrastructure, and updating margin assumptions position Centene for long-term success.

Centene reports strong Q2 earnings, raises 2023 outlook amidst challenges

Centene's Q2 earnings call showcased robust financial performance, operational efficiencies, and strategic wins in Medicaid and Marketplace segments. While facing challenges in cost trends and Star ratings strategy, the company is well-positioned for growth through revenue expansion and value-creation initiatives. Opportunities for engagement with key stakeholders and successful outreach efforts present avenues for continued success.

Centene exceeds Q3 earnings expectations, eyes growth opportunities in 2024

Centene's Q3 2023 earnings call highlighted strong financial performance, progress in Medicaid redeterminations, and operational advancements. The company anticipates continued growth in adjusted EPS for 2023 and 2024, with a focus on margin expansion and operational efficiencies. Challenges include managing membership declines and addressing questions on business plans and cost implications.

Centene exceeds 2023 expectations, poised for growth in 2024

Centene's 2023 performance was strong, exceeding expectations and positioning the company for continued growth. Key initiatives in Medicaid, Medicare Advantage, and Marketplace are driving revenue growth and operational efficiency. Challenges in managing utilization trends and achieving target margins require ongoing attention.

Centene surpasses Q1 earnings expectations, eyes growth in Medicaid and Marketplace

Centene's Q1 performance exceeded expectations, showcasing strength in Medicaid and Marketplace segments.
While facing challenges in contract protests and operational clarity, the company's strategic focus on Medicare Advantage and growth opportunities remain key strengths.
With a robust financial outlook and ongoing initiatives for optimization, Centene is well-positioned for continued success in the healthcare market.
Investors can be optimistic about Centene's growth trajectory, supported by strong operational performance and strategic initiatives.

Centene reports robust Q2 earnings, eyes Medicaid rebound and Medicare growth

Centene's Q2 2024 earnings call highlighted strong performance, Medicaid challenges, and growth opportunities in Medicaid and Medicare markets. Leadership transitions and focus on program innovation are key areas of development for the company.

Centene surpasses Q3 earnings expectations, eyes growth amid challenges

Centene's Q3 performance exceeded expectations, driven by improvements in Medicaid and strong Medicare and Marketplace segments.
Despite challenges in Medicaid and competitive pressures, Centene remains confident in its future growth and operational enhancements.
The company's strategic focus on AI, margin expansion, and quality improvement positions it well for continued success and profitability.
Analyst inquiries and company responses highlighted key areas of focus and potential areas for improvement and growth.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Centene Corp. is a healthcare enterprise, which engages in the provision of programs and services to government sponsored healthcare programs. It operates through the following segments: Medicaid, Medicare, Commercial, and Other. The Medicaid segment includes the Temporary Assistance for Needy Families program, Medicaid Expansion programs, the Aged, Blind or Disabled program, the Children's Health Insurance Program, Long-Term Services and Supports, Foster Care, Medicare-Medicaid Plans, which cover beneficiaries who are dually eligible for Medicaid and Medicare, and other state-based programs. The Medicare segment consists of Medicare Advantage, Medicare Supplement, Dual Eligible Special Needs Plans, and Medicare Prescription Drug Plans. The Commercial segment is involved in the Health Insurance Marketplace product along with individual, small group, and large group commercial health insurance products. The Other segment refers to pharmacy operations, Envolve Benefit Options’ vision and dental services, clinical healthcare, behavioral health, international operations, and corporate management companies. The company was founded in 1984 and is headquartered in St. Louis, MO.

In the latest trading session, Centene (CNC) closed at $45.36, marking a +0.73% move from the previous day.

Centene (CNC) Outpaces Stock Market Gains: What You Should Know

Allergan

Humana

UnitedHealth Group

WellCare Health Plans

Hedge funds continue to rotate out of tech stocks and into health care despite increased regulatory threats to the sector.

Hedge Funds Pile Into Health Care

DaVita

Illumina

Andreas Halvorsen (Trades, Portfolio), founding partner and chief investment officer of Viking Global Investors, bought shares of the following stocks in both the first and second quarters.

Andreas Halvorsen Keeps Buying Centene, DaVita and more.

Centene (CNC) reported earnings 30 days ago. What's next for the stock?

Why Is Centene (CNC) Down 12.7% Since Last Earnings Report?

Centene (CNC) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

Centene (CNC) Moves to Buy: Rationale Behind the Upgrade

Centene (CNC) to increase offerings in the 2020 Health Insurance Marketplace across 10 U.S. state markets.

Centene Expands Existence in Health Insurance Marketplace

Advance Auto Parts

Hormel Foods

The stock charts of Centene, Hormel Foods and Advance Auto Parts are each knocking on the door of trade-worthy moves.
The post 3 Big Stock Charts for Tuesday: Centene, Hormel Foods and Advance Auto Parts appeared first on InvestorPlace.

3 Big Stock Charts for Tuesday: Centene, Hormel Foods and Advance Auto Parts

Fortinet

Glu Mobile

Inter Parfums

Remark Hlds

Want to try an out-of-the-box approach? Tap five stocks with increasing P/E ratios.

Bet on Rising P/E Stocks to Enjoy Solid Gains

Canadian Solar

Legg Mason

SYNNEX

P/B ratio is emerging as a convenient tool for identifying low-priced stocks that have high growth prospects.

6 Promising Price-to-Book Value Stocks to Buy in August

Centene (CNC) is well positioned to outperform the market, as it exhibits above-average growth in financials.

3 Reasons Why Centene (CNC) Is a Great Growth Stock

The health insurer posts strong revenue and earnings growth as it awaits approval to acquire WellCare Health Plans.

Centene Hits a Home Run with Its Q2 Earnings Results

Centene's (CNC) CEO Michael Neidorff on Q2 2019 Results - Earnings Call Transcript

Centene's (CNC) second-quarter earnings benefit from higher revenues and operational efficiency.

Centene's (CNC) Q2 Earnings Beat Estimates, Improve Y/Y

Centene CNC, -0.89% lifted its earnings guidance after reporting a rise in second-quarter profit.

Centene lifts guidance after topping second-quarter estimates

Centene's (CNC) Q2 earnings are likely to be cushioned by higher revenues and membership.

Is a Beat in the Cards for Centene's (CNC) Q2 Earnings?

Centene is lagging behind its peers trading at 11x P/E 2020 vs. 15x for the sector's average.

Centene: A Growth Healthcare Stock At A Bargain Value

AmerisourceBergen

Anthem

The Trump administration announced Thursday that it's deciding to withdraw its proposal to eliminate rebates from government drug plans.

Trump Drops Drug Rebate Proposal: What's Next and What Stocks to Play

Cigna

CVS Health

Health Insurance Innovations

Magellan Health

Molina Healthcare

These stocks stand at the forefront of a growing multibillion-dollar industry.

The 10 Biggest Health Insurance Stocks

Centene Corporation is undervalued on fundamentals, especially in light of its recent dealmaking.

Centene Undervalued; Patient Shareholders Will Profit

Centene (CNC) buys a surplus share in Ribera Salud to fortify its footprint in Europe.

Centene (CNC) Acquires Additional Stake in Ribera Salud

American Airlines

Mosaic

The stock charts of Mosaic, Centene and American Airlines are moving into positions that portend more meaningful price changes.

3 Big Stock Charts for Tuesday: Mosaic, Centene and American Airlines

Concho Resources

Royal Caribbean Cruises

SK Telecom Co., Ltd.

According to the GuruFocus All-in-One Screener, the following companies are trading at a discount and have positive three- to five-year future earnings estimates.

5 Companies Boosting Earnings (June 27)

BB&T

Salesforce

Tableau Software

Danaher

First Data

Fiserv

General Electric

Newmont Mining

Pfizer

The $28 billion acquisition is the eighth-largest bank deal of all time. It’s expected to close in the fourth quarter.

The 7 Best Acquisitions of 2019

Alphabet

Tech stocks generally underperformed their peers on a rough day on Wall Street.

Why Facebook, Alphabet, and Centene Slumped Today

News that a Centene-Humana deal isn't in the works has CNC stock falling on Monday after an official statement was made by Humana.

News for Centene Stock (CNC)